The 12-year-old Sephardi adolescents will be vaccinated against Class A, C, W and Y maningococcus, instead of defending only type C, as agreed by the Autonomous Communities and the Ministry of Health. However, the Commission on Public Health intends to adapt to changes in pollution patterns in Spain, according to a note. This step has already been announced by the new Andalusian government. On the other hand, the refusal to public funds for the Meningococcal B vaccine was maintained, although its sale was liberalized, and sources from the Children's Association of Sephardic Children believed that one-third of the parents had purchased it to put it on its own. Infants
The ILA justifies its position on the Meningococcal vaccine by showing "a short period of protection after vaccination" in which there is a "lack of protection in the population without sex," "lack of effective, high-reactivity data when administered together with vaccine This year at the baby stage. "
With this change, the immunization schedule is as follows: immunization against maningococcal C at birth, and against the four strands (A, C, W and Y) at age 12, although it will also be extended to the adult population up to 18 to create adequate group protection, By health. The measure is consistent with the recommendations of the Spanish Children's Association, which also calls for Mennonococcus B (famous Bexero). This drug is already offered by Castile y León for children and youth, and by the Canary Islands, for teenagers.
Meningitis, in general, has two ways to manifest itself. The usual is having fever, headaches, nausea, skin spots, mood changes and nausea and vomiting. Since meningococci are bacteria, they are treated with antibiotics. In the other version, the infection is common, sepsis occurs, and the fatal result can be reached within hours. These are the cases that create the alarm. We must also remember that meningococci are just one of the causes of meningitis, which can be caused by other bacteria or by viruses (much more dangerous because they do not react to antibiotics, but rarely).
Data from the current meningococcal meningitis season, which began on October 8, indicate the epidemiological record of the Carlos III Health Institute, that by March 2, 180 confirmed cases had been reported in Spain and 12 others. Of these, 20 (11%) were mortal. In the previous season, by then, 180 cases had been confirmed with 26 deaths (14%).
As you can see, the total number is the same. But if the serogroups are identified every year are seen, it is observed that these type B decreased from 63 to 41; Those of C from 12 to 10, but those of W increased from 7 to 15 and those of Y from 9 to 12. That is, within the very low prevalence, there is a change towards the groups which so far had no vaccine. The displacement of serogroups was quite rapid. Data for the same period in 2014 include 62 cases of serogroup B and 5 cases of A, C, W and Y.
In all the statistics, meningococcal meningitis is caused by other non-printed or unknown groups. This suggests that if the vaccine can be extended to A, C, W, and Y in the pubic system, with the addition of family-initiated B, others may appear or become stronger when the groups are now prevalent. Be more controlled.